106 related articles for article (PubMed ID: 20591832)
1. Efficacy of rituximab in a patient with lupus nephritis despite low levels of CD19.
Bacconnier L; Combe B; Canaud B; Morel J
Rheumatology (Oxford); 2010 Dec; 49(12):2452-3. PubMed ID: 20591832
[No Abstract] [Full Text] [Related]
2. Rituximab-treated membranous lupus nephritis: clinical outcome and effects on electron dense deposits.
Jónsdóttir T; Sundelin B; Welin Henriksson E; van Vollenhoven RF; Gunnarsson I
Ann Rheum Dis; 2011 Jun; 70(6):1172-3. PubMed ID: 21367763
[No Abstract] [Full Text] [Related]
3. Early onset neutropenia after rituximab in lupus nephritis.
Enríquez R; Borrás-Blasco J; Sirvent AE; Masía M; Amorós F
Clin Exp Rheumatol; 2007; 25(2):345. PubMed ID: 17543172
[No Abstract] [Full Text] [Related]
4. Rituximab versus oral cyclophosphamide for treatment of relapses of proliferative lupus nephritis: a clinical observational study.
Moroni G; Gallelli B; Sinico RA; Romano G; Sinigaglia L; Messa P
Ann Rheum Dis; 2012 Oct; 71(10):1751-2. PubMed ID: 22586177
[No Abstract] [Full Text] [Related]
5. CD19 mRNA quantification improves rituximab treatment-to-target approach: a proof of concept study.
Marnetto F; Granieri L; Valentino P; Capobianco M; Pautasso M; Bertolotto A
J Neuroimmunol; 2014 Dec; 277(1-2):127-33. PubMed ID: 25293807
[TBL] [Abstract][Full Text] [Related]
6. Serum BLC/CXCL13 concentrations and renal expression of CXCL13/CXCR5 in patients with systemic lupus erythematosus and lupus nephritis.
Lee HT; Shiao YM; Wu TH; Chen WS; Hsu YH; Tsai SF; Tsai CY
J Rheumatol; 2010 Jan; 37(1):45-52. PubMed ID: 19955043
[TBL] [Abstract][Full Text] [Related]
7. Belimumab after rituximab as maintenance therapy in lupus nephritis.
Kraaij T; Huizinga TW; Rabelink TJ; Teng YK
Rheumatology (Oxford); 2014 Nov; 53(11):2122-4. PubMed ID: 25205827
[No Abstract] [Full Text] [Related]
8. Immunologic reconstitution after rituximab in systemic lupus erythematosus: why should we care?
Anolik J
J Rheumatol; 2011 Apr; 38(4):587-9. PubMed ID: 21459953
[No Abstract] [Full Text] [Related]
9. Refractory anti-synthetase syndrome treated with rituximab.
Ball EM; Savage EM; Pendleton A
Rheumatology (Oxford); 2010 May; 49(5):1013. PubMed ID: 20032227
[No Abstract] [Full Text] [Related]
10. Lupus, "rhupus" and "sjrupus".
Prabhakaran S; Handler RP
J Rheumatol; 2011 Feb; 38(2):393. PubMed ID: 21285180
[No Abstract] [Full Text] [Related]
11. Successful use of rituximab in recalcitrant skin predominant dermatomyositis.
Joshi N; Nautiyal A; Davies PG
J Clin Rheumatol; 2011 Mar; 17(2):111-2. PubMed ID: 21364354
[No Abstract] [Full Text] [Related]
12. [Is rituximab effective for induction of remission in lupus nephritis?].
Mac-Namara M; Rada G
Medwave; 2014 Aug; 14(7):e6010. PubMed ID: 25334007
[TBL] [Abstract][Full Text] [Related]
13. Late response to rituximab in a dialysis patient with severe lupus nephritis.
Hussein MM; Mooij JM; Al Malki N; Demerdash TM
Saudi J Kidney Dis Transpl; 2013 Sep; 24(5):976-80. PubMed ID: 24029264
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of rituximab in 164 patients with biopsy-proven lupus nephritis: pooled data from European cohorts.
Díaz-Lagares C; Croca S; Sangle S; Vital EM; Catapano F; Martínez-Berriotxoa A; García-Hernández F; Callejas-Rubio JL; Rascón J; D'Cruz D; Jayne D; Ruiz-Irastorza G; Emery P; Isenberg D; Ramos-Casals M; Khamashta MA;
Autoimmun Rev; 2012 Mar; 11(5):357-64. PubMed ID: 22032879
[TBL] [Abstract][Full Text] [Related]
15. Idiopathic orbital inflammation successfully treated using rituximab in a patient with rheumatoid arthritis.
Ibrahim I; Barton A; Ibrahim A; Ho P
J Rheumatol; 2012 Jul; 39(7):1485-6. PubMed ID: 22753803
[No Abstract] [Full Text] [Related]
16. [The LUNAR study: rituximab for lupus nephritis?].
Specker C
Z Rheumatol; 2013 Apr; 72(3):300-2. PubMed ID: 23262655
[No Abstract] [Full Text] [Related]
17. Clinical improvements in proliferative vs membranous lupus nephritis following B-cell depletion: pooled data from two cohorts.
Jónsdóttir T; Gunnarsson I; Mourão AF; Lu TY; van Vollenhoven RF; Isenberg D
Rheumatology (Oxford); 2010 Aug; 49(8):1502-4. PubMed ID: 20427294
[TBL] [Abstract][Full Text] [Related]
18. [Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy in Poland].
Samborski W; Buczek J; Bednarek A; Lewandowicz J; Kucharz E
Pol Merkur Lekarski; 2010 Dec; 29(174):365-8. PubMed ID: 21298986
[TBL] [Abstract][Full Text] [Related]
19. [Rituximab for treatment of graves orbitopathy].
Huerva V
Arch Soc Esp Oftalmol; 2011 May; 86(5):162-3. PubMed ID: 21624658
[No Abstract] [Full Text] [Related]
20. Acanthamoeba encephalitis in a patient with systemic lupus treated with rituximab.
Alkhunaizi AM; Dawamneh MF; Banda RW; Daabil RA; Al-Tawfiq JA; Akkad SA; Boukhamseen AH
Diagn Microbiol Infect Dis; 2013 Feb; 75(2):192-4. PubMed ID: 23265295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
